March 27th, 2026

12:00 PM, Lunch provided

Explore how psychedelic-assisted therapies may address critical gaps in women's healthcare. Drawing on emerging research and clinical applications, this course examines the potential of compounds like ketamine, psilocybin, and MDMA for treating conditions including hormonal mood disorders, chronic pain, trauma, and perinatal mental health challenges. Learn how to integrate psychedelic therapies into treatment models that account for hormonal cycles, life-stage transitions, and trauma-informed care. This course also covers practical protocols for ketamine-assisted psychotherapy, the role of cyclical intelligence in treatment planning, and archetypal frameworks (Maiden, Mother, Crone, Mage) as guides for holistic care, and addresses current research gaps and strategies for designing more inclusive, gender-informed clinical trials in psychedelic medicine. All material is grounded in the best available research, while transparently acknowledging that much of this science remains emergent and in need of further clinical validation.

Live taught online on April 3rd, 9 am PST or purchase the recorded course